Disclosure Of Fair Value Measurement [Text Block]

Biocartis Group NV - Filing #3123157

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
142,480,000 EUR
210,517,000 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
526,405,000 EUR
5,572,000 EUR
33,897,000 EUR
33,897,000 EUR
711,874,000 EUR
6,862,000 EUR
220,657,000 EUR
455,343,000 EUR
36,824,000 EUR
220,657,000 EUR
5,153,000 EUR
711,874,000 EUR
6,102,000 EUR
36,824,000 EUR
84,480,000 EUR
5,291,000 EUR
84,480,000 EUR
698,027,000 EUR
392,259,000 EUR
4,670,000 EUR
220,668,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.